Nurse-led Decision Counseling on Hepatocellular Carcinoma Screening
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Feasibility and Efficacy of Perioperative Nivolumab With or Without Relatlimab for Patients With Potentially Resectable Hepatocellular Carcinoma (HCC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
HCV Related Hepatocellular Carcinoma Recurrence After Directly Acting Antivirals: A Randomized Controlled Trial
- Status
- COMPLETED
- Phase
- PHASE4
Safety and Efficacy of DEB-TACE Performed With a Novel Reflux-control Microcatheter in Patients With HCC
- Status
- UNKNOWN
- Phase
- N/A
Perioperative Therapy for Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
MR Quality + Diagnostic Performance for CHC Diagnosis - Gadoxetic Acid, Gadoteric Acid and P03277 Comparison
- Status
- COMPLETED
- Phase
- N/A
Tislelizumab in Combination With TACE in Advanced Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Ablation Combined With PD-1 in HCC: Phase II Study
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
The Effect of Mobile Health-based Exercise on Hepatocellular Carcinoma Patients With Insulin Resistance
- Status
- TERMINATED
- Phase
- NA
Lenvatinib Combined With Gefitinib in the Treatment of Lenvatinib-resistant Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- NA
Substudy: Interconnection of Arterial Tumor Feeders Through Tumor Sinusoid in HCC
- Status
- COMPLETED
- Phase
- NA
TIPS Combined With Microwave Ablation in HCC Patients With Refractory Ascites
- Status
- UNKNOWN
- Phase
- NA
Anti-angiogenic Agents Plus Anti-PD-1 Antibodies for uHCC
- Status
- UNKNOWN
- Phase
- N/A
Observational Study on Patients With Hepatobiliary Tumors
- Status
- UNKNOWN
- Phase
- N/A
A Study on the Safety and Effectiveness of IBI318 Combined With Conventional TACE (cTACE) as a Perioperative Treatment for Potentially Resected Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1
Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of INCB086550 in Select Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
HAIC Combined With Bevacizumab and Toripalimab for Advanced Hepatocellular Carcinama
- Status
- UNKNOWN
- Phase
- PHASE2
Lenvatinib Combined Anti-PD1 Antibody for the Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- N/A
Volatile Organic Compounds for the Assessment of Liver Disease
- Status
- COMPLETED
- Phase
- N/A